期刊文献+

尼莫地平(nimodipine)对体外培养成骨细胞的影响 被引量:2

The effects of nimodiping on osteobl asts in vitro.
下载PDF
导出
摘要 目的观察钙通道阻断剂———尼莫地平(nimodipine)对体外培养成骨细胞的作用。方法在新生SD大鼠头颅骨第二继代成骨细胞(OB2)培养液中分别加入不同浓度(10-4~10-12g/ml)尼莫地平,分别观察OB2的增殖功能(用波长570nm处OD值表示),分化功能犤用碱性磷酸酶(ALP)活性表示犦和矿化功能(用矿化结节数量/视野表示)。结果OD值(均值±sf标准差)为0.121±0.009~0.411±0.035;ALP活性(均数±标准差)为0.092±0.008U/mg蛋白质;矿化结节数量/视野(均数±标准差)为1.250±0.893个。结论与对照组比较,尼莫地平各浓度对OB2的增殖、分化和矿化功能作用各异。当尼莫地平浓度为10-9g/ml时,对OB2的增殖和分化功能具有刺激作用(p<0.05),对OB2的增殖功能具有明显的抑制作用(p<0.01);当浓度降低(10-11g/ml)时,对OB2的增殖功能失去作用(p>0.05)。 Objective To observe the effects of nimodipine,a calcium channel blocker on osteob lasts in vitro.Methods The culture medium with different ni modipine concentrations(10-4~10-12 g /ml )and the sec-ond generation osteoblasts(OB2)fromthe skull of newborn SDrat were m ixed for the observation respective ly about the proliferation(OD value at wave length 570nm),the differentiation(ALP activity)and the mineralization(mineralizednodus /field of vision)of the OB2.Results The OD value(mean and standard deviation)was0.121±0.009~0.411±0.035;the ALP a ctivity(mean and standard deviation)was 0.092±0.008U/mg proteins and the mineralized nodus(mean and standard deviation)was 1.250±0.893.Conclusion By comparision with controlling goups,the prolife ration and differentiation of the OB2 were separately increased(p <0.05)by 10-9 g /ml nimodipine concentration,but th e mineralization was significantly inhibited(p <0.01).The proliferation of the OB2 was significantly inhibited(p <0.01)when escalated nimodipine concentr ation was at the 10-5 g /ml,the proliferation was not effected(p>0.05)when descended nimodipine concentr ation was at the 10 -11 g /ml.[
出处 《中国创伤骨科杂志》 CSCD 2001年第1期38-40,共3页
基金 本课题是上海市徐汇区卫生局科研基金资助项目
关键词 尼莫地平 钙通道阻断剂 成骨细胞 组织培养 骨折愈合 Nimodipinecalcium Channel blocker Rsteoblast Tissue culture Fracture healing
  • 相关文献

参考文献2

共引文献40

同被引文献102

  • 1[23]Schoofs MW, Van der klift M, Hofman A, et al. Thiazide diuretics and the risk for hip fracture. Ann Intern Med, 2003,139(6) :136.
  • 2[24]Nordin BE, Horowitz M, Need A, et al. Renal leak of calcium in postmenopausal osteoporosis. Clin Endocrinol (Oxf), 1994,41:41-45.
  • 3[25]Hea ney RP, Recker RR, Ryan RA. Urinary calcium in perimenopausal women:normative values. Osteoporos Int, 1999,9:13-18.
  • 4[26]McKane WR, Khosla S, Burritt MF, et al. Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause-a clinical research center study. J clin Endocrinol Metab,1995,80: 3458-3464.
  • 5[27]Dvorak MM, Carter H, Riccardi D. Thiazide-sensitive sodium chloride co-transporter(NCC) in cryosections of rats and human bone. J Bone Miner Res, 2002, 17 (Suppl 1):247.
  • 6[28]Barry ELR, Gesek FA, Kaplan MR, et al. Expression of the sodiumchloride cotransporter in osteoblast-like cell: effects of thiazide diuretics. Am J Physiol, 1997,272:C109-C116.
  • 7[29]Lalande A, Roux S, Denne MA, et al. Indapamide, a thiazide-like diuretic decrease bone resorption in vitro. J Bone Miner Res, 2001,16:361-370.
  • 8[30]Aubin R, Menard P, Lajeunesse D. Selective effect of thiazide on the human osteoblast-like cell line MG-63. Kidney Int, 1996, 50: 1476-1482.
  • 9[31]Hall TJ, Schaueblin M. Hydrochlorothiazide inhibits osteoclastic bone resorption in vitro. Calcif Tissue Int, 1994,55: 266-268.
  • 10[32]Y.aturu S. Skeletal effects of statins. Endocrine Practic,2003,9:316-320

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部